RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53(abnormal) myeloma cells independently of the p53 pathway

BACKGROUND: The aim of this study was to evaluate the efficacy of the p53-reactivating drugs RITA and nutlin3a in killing myeloma cells. METHODS: A large cohort of myeloma cell lines (n = 32) and primary cells (n = 21) was used for this study. This cohort contained cell lines with various TP53 statu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Surget, Sylvanie, Descamps, Géraldine, Brosseau, Carole, Normant, Vincent, Maïga, Sophie, Gomez-Bougie, Patricia, Gouy-Colin, Nadège, Godon, Catherine, Béné, Marie C, Moreau, Philippe, Le Gouill, Steven, Amiot, Martine, Pellat-Deceunynck, Catherine
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4094448/
https://ncbi.nlm.nih.gov/pubmed/24927749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-437
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados